-
Mashup Score: 1
SAN DIEGO — Patients with ulcerative colitis who responded to mirikizumab at 12 weeks achieved and maintained clinical remission and improved bowel urgency severity at 1 year in the phase 3 LUCENT-2 study.“The primary endpoint of clinical remission and all key secondary endpoints across clinical, symptomatic, endoscopic and histological measures were met with significance and
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 0
SAN DIEGO — Patients with ulcerative colitis who responded to mirikizumab at 12 weeks achieved and maintained clinical remission and improved bowel urgency severity at 1 year in the phase 3 LUCENT-2 study.“The primary endpoint of clinical remission and all key secondary endpoints across clinical, symptomatic, endoscopic and histological measures were met with significance and
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
News from #DDW2022: Patients with #ulcerativecolitis who responded to #mirikizumab at 12 weeks achieved and maintained #clinical #remission and improved bowel urgency severity at 1 year in the phase 3 LUCENT-2 study #GITwitter https://t.co/BuGLiVxxxY @DDWMeeting https://t.co/QiTrBJ8JCu
-
-
Mashup Score: 1
SAN DIEGO — In a Healio video exclusive, Marla C. Dubinsky, MD, discusses results from the ELEVATE UC trials, in which once daily etrasimod induced clinical remission in patients with ulcerative colitis. “It was really exciting to see that we have yet another potential therapy that will be approved in this new class of small molecules known as S1P receptor modulators,” Dubsinky,
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
#ICYMI from #DDW2022: Oral S1P receptor modulator induces clinical remission in #UC @pfizer #DDW2022 #GITwitter #MedTwitter https://t.co/moBE3C5qVF
-
-
Mashup Score: 0VIDEO: Genetic testing identifies patients at increased risk for cancers, pancreatitis - 2 year(s) ago
SAN DIEGO — In a Healio video exclusive, study authors Howard P. Monsour, MD, and Carrie Milliard, discuss how genetic risk assessment and testing may help inform patient care and improve health outcomes.In research presented at Digestive Disease Week 2022, Monsour and colleagues found that implementing a genetic screening program in a rural GI practice led to the identification of 18% of
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
#ICYMI from #DDW2022: #Genetictesting identifies patients at increased risk for #cancers, #pancreatitis @DDWMeeting @AmbryGenetics #GITwitter #MedTwitter https://t.co/RPhsCwhDNA
-
-
Mashup Score: 010 Highlights From Digestive Disease Week 2022 - 2 year(s) ago
With a focus on newly approved treatments and those seemingly on the verge, this year’s meeting had clear practice-changing implications, says Dr David Johnson.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
🔟 abstracts that have potentially practice-changing implications for your practice. https://t.co/ixET16WtGx #DDW2022 #GITwitter https://t.co/d4MOJgBsua
-
-
Mashup Score: 0Debate: ‘Safety, adequacy, cost’ still favor percutaneous vs. endoscopic ultrasound biopsy - 2 year(s) ago
SAN DIEGO — Although percutaneous liver biopsy is still the “gold standard,” advances in techniques and increased use of endoscopic ultrasound-guided biopsy may soon change that dynamic, according to a debate at Digestive Disease Week 2022. “There are several advantages to [endoscopic ultrasound (EUS)-guided liver biopsy], not the least of which is patient comfort,”
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
#Debate: ‘Safety, adequacy, cost’ still favor percutaneous vs. endoscopic #ultrasound #biopsy #DDW2022 #GITwitter #MedTwitter @DDWMeeting https://t.co/JzZPuSf2fo
-
-
Mashup Score: 0
SAN DIEGO — In a Healio video exclusive, Marla C. Dubinsky, MD, discusses results from the ELEVATE UC trials, in which once daily etrasimod induced clinical remission in patients with ulcerative colitis. “It was really exciting to see that we have yet another potential therapy that will be approved in this new class of small molecules known as S1P receptor modulators,” Dubsinky,
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
In a Healio video exclusive, Marla Dubinsky, MD, of @IcahnMountSinai discusses results from the #ELEVATE #UC trials (@pfizer), in which once daily #etrasimod induced clinical remission in patients with #ulcerativecolitis @DDWMeeting #DDW2022 #GITwitter https://t.co/moBE3C5qVF https://t.co/5RCn5Dzlyc
-
-
Mashup Score: 2Recommendations based on race, ethnicity should be avoided in GI clinical guidelines - 2 year(s) ago
SAN DIEGO — Gastroenterology societies should refrain from incorporating race and ethnicity into clinical guidelines as doing so may exacerbate health inequities, according to research presented at Digestive Disease Week 2022. “Race is a social construct, yet health care workers still use race and ethnicity to guide clinical decision-making,” Shazia M. Siddique, MD, MSHP,
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
#DDW2022: @ShaziaMSiddique from .@pennmedicine .@pennldi .@pennmedcep said recommendations based on #race, #ethnicity should be avoided in GI clinical guidelines https://t.co/noX99Ej7Y4 #GITwitter #MedTwitter
-
-
Mashup Score: 0VIDEO: Genetic testing identifies patients at increased risk for cancers, pancreatitis - 2 year(s) ago
SAN DIEGO — In a Healio video exclusive, study authors Howard P. Monsour, MD, and Carrie Milliard, discuss how genetic risk assessment and testing may help inform patient care and improve health outcomes.In research presented at Digestive Disease Week 2022, Monsour and colleagues found that implementing a genetic screening program in a rural GI practice led to the identification of 18% of
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
In a Healio video exclusive, study authors Howard P. Monsour, MD, and Carrie Milliard, discuss how #geneticrisk assessment and testing may help inform #patientcare and improve health outcomes @DDWMeeting #DDW2022 #GITwitter #MedTwitter @AmbryGenetics https://t.co/RPhsCwhDNA
-
-
Mashup Score: 4Artificial Intelligence Colonoscopy System Shows Promise - 2 year(s) ago
A new artificial intelligence colonoscopy system improved the accuracy of experienced endoscopists in the United States.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
A new AI system can help expert endoscopists improve their colonoscopies, a new study indicates. https://t.co/bU9Z8usWrt #DDW2022
-
#Mirikizumab induces, maintains clinical remission at 1 year in #UC patients #DDW2022 @DDWMeeting #GITwitter #MedTwitter https://t.co/BuGLiVxxxY https://t.co/zQJnCo6rn2